A clinical trial to study the effectiveness of an ayurvedic drug preparation and ayurvedic psychotherapy in obsessive compulsive disorder

EFFECTIVENESS OF LASHUNA TAILA PAANA AND SATWAVAJAYA CHIKITSA IN ATATWABHINIVESHA (OBSESSIVE COMPULSIVE DISORDER)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010227

Enrollment

Registered

2017-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- obsessive compulsive disorder

Interventions

Intervention1: Lashuna Taila and Satwavajaya chikitsa in obsessive compulsive disorder: 20 diagnosed patients with obsessive compulsive disorder will be taken in a single group and lashuna taila will

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group - 16 to 60 years of either sex. 2) Diagnosed patients who are willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Major organic / systemic disorders like ischemic heart disease, essential hypertension, hypertensive emergency, chronic kidney disease, poorly controlled diabetes mellitus. 2) Major psychological disorders like schizophrenia. 3) Pregnant/Lactating mother. 4) Substance abuse other than nicotine dependency.

Design outcomes

Primary

Measure	Time frame
1)Decrease in symptoms may or may not be seen in 20 patients of OCD 2)Increase in cognitive level of 20 patients who suffered from OCD may or may not be observed 3)The specific duration of assessment which is 8th day and 22nd, 29th day during the treatment may help in concluding at which level the drug and therapy acted or not acted 4)Effect of the drug on bowel, appetite, micturititon is assessed 5)The 5 steps of self training is assessed and evaluated 6)Assessing through 2 Scales Timepoint: 28 days	—

Measure

Time frame

1)Decrease in symptoms may or may not be seen in 20 patients of OCD 2)Increase in cognitive level of 20 patients who suffered from OCD may or may not be observed 3)The specific duration of assessment which is 8th day and 22nd, 29th day during the treatment may help in concluding at which level the drug and therapy acted or not acted 4)Effect of the drug on bowel, appetite, micturititon is assessed 5)The 5 steps of self training is assessed and evaluated 6)Assessing through 2 Scales Timepoint: 28 days

—

Secondary

Measure	Time frame
1)Increase in symptoms if seen in 20 patients of OCD 2)Decrease in cognitive level of 20 patients who suffered from OCD if observed 3)Altered sleep 4)Results got through assessing Manasika Bhava scaleTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Manjunatha Adiga

SDM college of Ayurveda and hospital Hassan Karnataka

adiga.manjunatha@gmail.com9035715798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026